Debut Plus

₹847.1

▼ -7.69 -0.90%

11 Sept 2026

BSE Listed · Pharmaceuticals

Albert David Ltd. (524075)

Volume: 18Avg Vol 1W: 153Avg Vol 1M: 54952W Range:₹581.3₹925
BSE www.albertdavidindia.com AI Report
Key Ratios
Checked just now
Market Cap₹483 Cr
Current Price₹847.1
Previous Close₹854.79
High / Low (52w)₹925 / ₹581.3
Volume18
Avg Vol (1W)153
Avg Vol (1M)549
Stock P/E21.43
Book Value₹685.71
Dividend Yield58%
ROE-38.18%
ROA434.77%
Revenue (TTM)—
Revenue Growth—
Profit Margin6.19%
Total Debt—
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹39.52
P/B1.24
Debt / Equity0.05
50 DMA₹774.65
200 DMA₹732.64
Day change-0.90%
Price Chart
₹847.1▲ 5.41% · 1Y
₹972₹58727K
2025-09-11
2026-09-11

20-day avg volume: 538 shares

Pros
  • Pays a dividend yield of 58.0%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹98 Cr₹83 Cr₹75 Cr₹71 Cr₹87 Cr₹90 Cr₹86 Cr₹101 Cr
EBITDA₹25 Cr₹-10 Cr₹-12 Cr₹9 Cr₹-2 Cr₹21 Cr₹-25 Cr₹36 Cr
Net Profit₹18 Cr₹-9 Cr₹-10 Cr₹8 Cr₹-3 Cr₹15 Cr₹-21 Cr₹32 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹324 Cr₹328 Cr₹265 Cr₹329 Cr₹357 Cr₹420 Cr₹375 Cr₹341 Cr
EBITDA₹29 Cr₹30 Cr₹28 Cr₹48 Cr₹51 Cr₹98 Cr₹26 Cr₹3 Cr
Net Profit₹27 Cr₹19 Cr₹22 Cr₹35 Cr₹36 Cr₹75 Cr₹17 Cr₹-1 Cr
EPS46.6833.5938.861.7863.39132.1530.14-2.62
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹295 Cr₹320 Cr₹341 Cr₹401 Cr₹423 Cr₹498 Cr₹511 Cr₹519 Cr
Total Liabilities₹84 Cr₹97 Cr₹97 Cr₹122 Cr₹112 Cr₹115 Cr₹119 Cr₹128 Cr
Equity₹210 Cr₹223 Cr₹244 Cr₹279 Cr₹312 Cr₹383 Cr₹392 Cr₹392 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹39 Cr₹53 Cr₹26 Cr₹62 Cr₹-20 Cr₹-3 Cr
Investing₹-39 Cr₹-40 Cr₹-5 Cr₹-33 Cr₹23 Cr₹-4 Cr
Financing₹-2 Cr₹-2 Cr₹-6 Cr₹-8 Cr₹0 Cr₹12 Cr
Free Cash Flow₹39 Cr₹53 Cr₹26 Cr₹62 Cr₹-20 Cr₹-3 Cr
Shareholding
Promoter 62.24% Institutions 2.2% Public 35.56%
Efficiency & Working Capital
ROCE0.7%
Interest Coverage1.2
Dividend Payout—
Debtor Days37 d
Inventory Days64 d
Payable Days36 d
Cash Conversion Cycle65 d
Working Capital Days101 d
Shareholding Details

As of 2026-06-30

Promoter62.2%
FII0.6%
DII1.6%
Institutions2.2%
Public35.6%
Promoter Pledge0%
No. of Shareholders13,155
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters62%62%62.1%62.1%62.1%62.1%62.2%62.2%62.2%62.2%62.2%62.2%
FIIs0.6%0.7%1%0.8%0.9%0.9%1%0.8%0.6%0.6%0.6%0.6%
DIIs1.9%1.7%1.7%1.7%1.6%1.6%1.6%1.7%1.7%1.7%1.7%1.6%
Public35.5%35.6%35.2%35.4%35.3%35.4%35.1%35.3%35.5%35.5%35.5%35.6%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders9,90710,04111,26612,34913,59014,83015,30415,07014,66613,96713,55513,155
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Kothari Investment And Industries Private LimitedShareholding of Promoter and Promoter Group41.4%23,60,531
Anand Vardhan KothariShareholding of Promoter and Promoter Group9.9%5,66,500
M D Kothari And Company LimitedShareholding of Promoter and Promoter Group6.9%3,94,700
Kothari Phytochemicals & Industries LimitedShareholding of Promoter and Promoter Group1.7%99,200
Arun Kumar KothariShareholding of Promoter and Promoter Group1.7%97,000
General Insurance Corporation Of IndiaPublic Shareholding1.6%91,850
Vikabh Securities Pvt. Ltd.Public Shareholding1%57,250
Prabhawati Devi KothariShareholding of Promoter and Promoter Group0.3%17,527
Paramsukhdas Suganchand Huf (karta - Arun Kumar Kothari)Shareholding of Promoter and Promoter Group0.3%15,000
Vedika KothariShareholding of Promoter and Promoter Group0%1,500
Board of Directors
NameDesignationYear
A K KothariChairman & Exec. Director2026
P D KothariNon Executive Director2026
Anand Vardhan KothariNon Executive Director2026
Shourya SenguptaIndependent Non Exe. Director2026
Monjori MitraIndependent Non Exe. Director2026
ANURAG SINGHIIndependent Non Exe. Director2026
NARESH PACHISIAIndependent Non Exe. Director2026
Rajiv Anant DesaiIndependent Non Exe. Director2026
Amit MahlaWhole Time Director & CEO2026
LALIT LOHIACompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Manufacturing of pharmaceutical pro₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹101066
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-06Board Meetings—
forthcoming2026-07-30Dividend (5/- per share)Final
dividend2026-07-30₹5 (50%)Final
dividend2025-07-25₹5 (50%)Final
forthcoming—Book ClosureAGM & 50% Final Dividend
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000437
2026000011
2026000426
Insider / Designated-Person Trades

23 recent disclosure(s)

KOTHARI PHYTOCHEMICALS & INDUSTRIES LIMITEDAcquisition · 6,000
Kothari Phytochemicals & Industries LimitedAcquisition · 2,700
Kothari Investment & Industries Private LimitedAcquisition · 2,300
M D Kothari & Company LtdAcquisition · 1,006
Kothari Investment & Industires Private LimitedAcquisition · 2,000
Anand Vardhan KothariAcquisition · 1,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market18/02/2025 - 24/02/2025 · 6,000
Company Information
Incorporated1938
ChairmanA K Kothari
AuditorL B Jha & Co
Investor Email[email protected]; [email protected]
🌐 www.albertdavidindia.com ↗

📍 D Block 3rd Flr Gillander Hous, Netaji Subhas Road, Kolkata, West Bengal, 700001

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Kingfa Science & TechnologyPatidar Buildcon LimitedRama PhosphatesVenlon Enterprises Ltd.Pet Plastics Ltd.Panther Industrial Products Ltd.Haryana Leather Chemicals Ltd.Kabra ExtrusiontechnikVinyl ChemicalsPee Cee Cosma Sope Ltd.TCM Ltd.IOL Chemicals & PharmaceuticalsAll “52” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search